Finance

Lists
Why is VRCA down 10,72%?
Dive Deeper
VRCA:NASDAQ
Verrica Pharmaceuticals Inc
3,58 USD
-10,72%
(-0,43) 1D
3,60 USD
+0,56% (+0,020)
After hours
Closed: 13-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRCA...
Open
3,99 USD
High
4,38 USD
Low
3,51 USD
Mkt. cap
61,50 млн
Avg. vol.
49,84 миң
Volume
0,00
52-wk high
9,82 USD
52-wk low
3,28 USD
EPS
-1,67 USD
Beta
1,60
Shares outstanding
17,18 млн
No. of employees
76
Open
3,99 USD
High
4,38 USD
Low
3,51 USD
Mkt. cap
61,50 млн
Avg. vol.
49,84 миң
Volume
0,00
52-wk high
9,82 USD
52-wk low
3,28 USD
EPS
-1,67 USD
Beta
1,60
Shares outstanding
17,18 млн
No. of employees
76
News stories
From web sources and news partners
About Verrica Pharmaceuticals Inc
CEOJayson Rieger
Employees76
Founded2013
HeadquartersЗапад Честер, Пенсильвания, Америка Кошмо Штаттары
SectorPharmaceutical industry
Analyst ratings
Based on 4 analysts giving stock ratings to VRCA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for VRCA in the last 3 months.
Highest
Current 3,58 USD
20,00 USD (+458,66%)
Average
13,67 USD (+281,84%)
Lowest
9,00 USD (+151,40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
9,00 USD
+151,4%
10/01/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/27/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
12,00 USD
+235,2%
08/07/2026
Stacy Ku
TD Cowen
Buy
Reiterated
20,00 USD
+458,7%
08/06/2026
Kemp Dolliver
Brookline Capital Markets
Buy
Upgraded
17,00 USD
+374,9%
12/17/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
14,34 млн
5,09 млн
5,02 млн
5,86 млн
Cost of goods sold
3,31 млн
3,92 млн
4,75 млн
6,91 млн
Cost of revenue
3,31 млн
3,92 млн
4,75 млн
6,91 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,40 млн
8,12 млн
9,99 млн
10,35 млн
Operating expense
9,40 млн
8,12 млн
9,99 млн
10,35 млн
Total operating expenses
12,72 млн
12,04 млн
14,74 млн
17,26 млн
Operating income
1,63 млн
-6,95 млн
-9,72 млн
-11,40 млн
Other non operating income
34,00 миң
1,76 млн
-8,00 миң
-3,00 миң
EBT including unusual items
-274,00 миң
-8,07 млн
-9,68 млн
-13,15 млн
EBT excluding unusual items
-274,00 миң
-6,30 млн
-9,68 млн
-11,46 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-274,00 миң
-8,07 млн
-9,68 млн
-13,15 млн
Net profit margin
-1,91%
-158,56%
-192,75%
-224,38%
Earnings per share
0,13
-0,51
-0,45
-0,48
Interest and investment income
159,00 миң
205,00 миң
201,00 миң
111,00 миң
Interest expense
-2,09 млн
-1,31 млн
-160,00 миң
-164,00 миң
Net interest expenses
-1,94 млн
-1,11 млн
41,00 миң
-53,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
1,74 млн
-6,83 млн
-9,60 млн
-11,27 млн
Gain or loss from assets sale
68,00 миң
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору